{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:31:20Z","timestamp":1775086280296,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13408-x","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T04:53:33Z","timestamp":1736225613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making"],"prefix":"10.1186","volume":"25","author":[{"given":"Anna","family":"Vaynrub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin Eileen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subiksha","family":"Umakanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine D.","family":"Crew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Kukafka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"issue":"2","key":"13408_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75\u201389.","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"13408_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","volume":"29","author":"E Warner","year":"2011","unstructured":"Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, et al. Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol. 2011;29(13):1664\u20139.","journal-title":"J Clin Oncol"},{"issue":"23","key":"13408_CR3","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316.","journal-title":"JAMA"},{"issue":"5","key":"13408_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"13408_CR5","doi-asserted-by":"crossref","unstructured":"Anglian Breast Cancer Study G. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer. 2000;83(10):1301\u20138.","DOI":"10.1054\/bjoc.2000.1407"},{"issue":"9","key":"13408_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","volume":"148","author":"E Warner","year":"2008","unstructured":"Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008;148(9):671\u20139.","journal-title":"Ann Intern Med"},{"issue":"10","key":"13408_CR7","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.ejso.2008.03.002","volume":"34","author":"AE Isern","year":"2008","unstructured":"Isern AE, Loman N, Malina J, Olsson H, Ringberg A. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. Eur J Surg Oncol. 2008;34(10):1148\u201354.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"13408_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","volume":"26","author":"ND Kauff","year":"2008","unstructured":"Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol. 2008;26(8):1331\u20137.","journal-title":"J Clin Oncol"},{"issue":"2","key":"13408_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101(2):80\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"13408_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967\u201375.","journal-title":"JAMA"},{"issue":"15","key":"13408_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","volume":"32","author":"AP Finch","year":"2014","unstructured":"Finch AP, Lubinski J, Moller P, Singer CF, Karlan B, Senter L, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2014;32(15):1547\u201353.","journal-title":"J Clin Oncol"},{"issue":"7","key":"13408_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.10987","volume":"322","author":"DK Owens","year":"2019","unstructured":"Force USPST, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. JAMA. 2019;322(7):652\u201365.","journal-title":"JAMA"},{"issue":"4","key":"13408_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/M13-2747","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA, Force USPST. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(4):271\u201381.","journal-title":"Ann Intern Med"},{"issue":"4","key":"13408_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1158\/1055-9965.EPI-12-1280","volume":"22","author":"CA Bellcross","year":"2013","unstructured":"Bellcross CA, Leadbetter S, Alford SH, Peipins LA. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral. Cancer Epidemiol Biomarkers Prev. 2013;22(4):728\u201335.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"13408_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cge.12868","volume":"92","author":"AM Willis","year":"2017","unstructured":"Willis AM, Smith SK, Meiser B, Ballinger ML, Thomas DM, Young MA. Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review. Clin Genet. 2017;92(2):121\u201333.","journal-title":"Clin Genet"},{"issue":"5","key":"13408_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/1055-9965.EPI-05-0002","volume":"15","author":"ME Ropka","year":"2006","unstructured":"Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT. Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev. 2006;15(5):840\u201355.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"13408_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s11606-009-1009-6","volume":"24","author":"DE Levy","year":"2009","unstructured":"Levy DE, Garber JE, Shields AE. Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization. J Gen Intern Med. 2009;24(7):822\u20138.","journal-title":"J Gen Intern Med"},{"issue":"3\u20134","key":"13408_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000336419","volume":"15","author":"G Joseph","year":"2012","unstructured":"Joseph G, Kaplan C, Luce J, Lee R, Stewart S, Guerra C, et al. Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach. Public Health Genomics. 2012;15(3\u20134):172\u201380.","journal-title":"Public Health Genomics"},{"issue":"6","key":"13408_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/GIM.0b013e3181770184","volume":"10","author":"AE Shields","year":"2008","unstructured":"Shields AE, Burke W, Levy DE. Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med. 2008;10(6):404\u201314.","journal-title":"Genet Med"},{"issue":"14","key":"13408_CR20","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1200\/JCO.2006.05.5889","volume":"24","author":"MJ Hall","year":"2006","unstructured":"Hall MJ, Olopade OI. Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol. 2006;24(14):2197\u2013203.","journal-title":"J Clin Oncol"},{"issue":"9","key":"13408_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/GIM.0b013e31821a36f9","volume":"13","author":"J Vos","year":"2011","unstructured":"Vos J, Stiggelbout AM, Oosterwijk J, Gomez-Garcia E, Menko F, Collee JM, et al. A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees\u2019 risk perception shortly after BRCA1\/2 test result disclosure. Genet Med. 2011;13(9):800\u201311.","journal-title":"Genet Med"},{"issue":"4","key":"13408_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41431-018-0310-4","volume":"27","author":"C Jacobs","year":"2019","unstructured":"Jacobs C, Patch C, Michie S. Communication about genetic testing with breast and ovarian cancer patients: a scoping review. Eur J Hum Genet. 2019;27(4):511\u201324.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"13408_CR23","doi-asserted-by":"publisher","first-page":"e2222092","DOI":"10.1001\/jamanetworkopen.2022.22092","volume":"5","author":"R Kukafka","year":"2022","unstructured":"Kukafka R, Pan S, Silverman T, Zhang T, Chung WK, Terry MB, et al. Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial. JAMA Netw Open. 2022;5(7):e2222092.","journal-title":"JAMA Netw Open"},{"issue":"28","key":"13408_CR24","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","volume":"33","author":"JA Tice","year":"2015","unstructured":"Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol. 2015;33(28):3137\u201343.","journal-title":"J Clin Oncol"},{"issue":"7","key":"13408_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1200\/JCO.22.02470","volume":"42","author":"CC Gard","year":"2024","unstructured":"Gard CC, Tice JA, Miglioretti DL, Sprague BL, Bissell MCS, Henderson LM, et al. Extending the breast cancer surveillance consortium model of invasive breast cancer. J Clin Oncol. 2024;42(7):779\u201389.","journal-title":"J Clin Oncol"},{"issue":"6","key":"13408_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000452095","volume":"19","author":"SL Stewart","year":"2016","unstructured":"Stewart SL, Kaplan CP, Lee R, Joseph G, Karliner L, Livaudais-Toman J, et al. Validation of an efficient screening tool to identify low-income women at high risk for hereditary breast cancer. Public Health Gen. 2016;19(6):342\u201351.","journal-title":"Public Health Gen"},{"issue":"3","key":"13408_CR27","first-page":"411","volume":"30","author":"K Krippendorff","year":"2004","unstructured":"Krippendorff K. Reliability in content analysis: some common misconceptions and recommendations. Human Commun Res. 2004;30(3):411\u201333.","journal-title":"Human Commun Res"},{"issue":"11","key":"13408_CR28","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/ejhg.2016.68","volume":"24","author":"BJ Wilson","year":"2016","unstructured":"Wilson BJ, Islam R, Francis JJ, Grimshaw JM, Permaul JA, Allanson JE, et al. Supporting genetics in primary care: investigating how theory can inform professional education. Eur J Hum Genet. 2016;24(11):1541\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"13408_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pec.2011.04.017","volume":"86","author":"J Vos","year":"2012","unstructured":"Vos J, Oosterwijk JC, Gomez-Garcia E, Menko FH, Collee MJ, van Asperen CJ, et al. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees\u2019 perception matters, but the actual BRCA1\/2 result does not. Patient Educ Couns. 2012;86(2):239\u201351.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"13408_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ijc.32396","volume":"146","author":"C Engel","year":"2020","unstructured":"Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, et al. Breast cancer risk in BRCA1\/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer. 2020;146(4):999\u20131009.","journal-title":"Int J Cancer"},{"key":"13408_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/EDBK_158817","volume":"35","author":"AW Kurian","year":"2016","unstructured":"Kurian AW, Antoniou AC, Domchek SM. Refining breast cancer risk stratification: additional genes, additional information. Am Soc Clin Oncol Educ Book. 2016;35:44\u201356.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"13408_CR32","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1200\/OP.20.00256","volume":"17","author":"A Laws","year":"2021","unstructured":"Laws A, Mulvey TM. Implementation of a high-risk breast clinic for comprehensive care of women with elevated breast cancer risk identified by risk assessment models in the community. JCO Oncol Pract. 2021;17(2):e217\u201325.","journal-title":"JCO Oncol Pract"},{"key":"13408_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bpobgyn.2019.11.006","volume":"65","author":"MA Thorat","year":"2020","unstructured":"Thorat MA, Balasubramanian R. Breast cancer prevention in high-risk women. Best Pract Res Clin Obstet Gynaecol. 2020;65:18\u201331.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"13408_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10897-015-9836-6","volume":"24","author":"AH Buchanan","year":"2015","unstructured":"Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, et al. Randomized trial of telegenetics vs. In-person cancer genetic counseling: cost, patient satisfaction and attendance. J Genet Couns. 2015;24(6):961\u201370.","journal-title":"J Genet Couns"},{"issue":"2","key":"13408_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/ijgc-2019-000630","volume":"30","author":"L McLeavy","year":"2020","unstructured":"McLeavy L, Rahman B, Kristeleit R, Ledermann J, Lockley M, McCormack M, et al. Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process. Int J Gynecol Cancer. 2020;30(2):221\u20136.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"13408_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10897-017-0200-x","volume":"27","author":"HA Zierhut","year":"2018","unstructured":"Zierhut HA, MacFarlane IM, Ahmed Z, Davies J. Genetic counselors\u2019 experiences and interest in telegenetics and remote counseling. J Genet Couns. 2018;27(2):329\u201338.","journal-title":"J Genet Couns"},{"issue":"2","key":"13408_CR37","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.2196\/jmir.4564","volume":"18","author":"A Bradbury","year":"2016","unstructured":"Bradbury A, Patrick-Miller L, Harris D, Stevens E, Egleston B, Smith K, et al. Utilizing remote real-time videoconferencing to expand access to cancer genetic services in community practices: a multicenter feasibility study. J Med Internet Res. 2016;18(2):e23.","journal-title":"J Med Internet Res"},{"issue":"9","key":"13408_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/gim.2012.40","volume":"14","author":"JS Hilgart","year":"2012","unstructured":"Hilgart JS, Hayward JA, Coles B, Iredale R. Telegenetics: a systematic review of telemedicine in genetics services. Genet Med. 2012;14(9):765\u201376.","journal-title":"Genet Med"},{"issue":"7","key":"13408_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/10810730.2020.1788677","volume":"25","author":"SJ Hong","year":"2020","unstructured":"Hong SJ, Goodman M, Kaphingst KA. Relationships of family history-related factors and causal beliefs to cancer risk perception and mammography screening adherence among medically underserved women. J Health Commun. 2020;25(7):531\u201342.","journal-title":"J Health Commun"},{"issue":"5","key":"13408_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.acra.2020.03.041","volume":"28","author":"N Amornsiripanitch","year":"2021","unstructured":"Amornsiripanitch N, Ameri SM, Goldberg RJ. Impact of age, race, and socioeconomic status on women\u2019s perceptions and preferences regarding communication of estimated breast cancer risk. Acad Radiol. 2021;28(5):655\u201363.","journal-title":"Acad Radiol"},{"issue":"2","key":"13408_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ejhg.2014.84","volume":"23","author":"C Jacobs","year":"2015","unstructured":"Jacobs C, Dancyger C, Smith JA, Michie S. Accuracy of recall of information about a cancer-predisposing BRCA1\/2 gene mutation among patients and relatives. Eur J Hum Genet. 2015;23(2):147\u201351.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"13408_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000439162","volume":"19","author":"CL Scherr","year":"2016","unstructured":"Scherr CL, Christie J, Vadaparampil ST. Breast cancer survivors\u2019 knowledge of hereditary breast and ovarian cancer following genetic counseling: an exploration of general and survivor-specific knowledge items. Public Health Genomics. 2016;19(1):1\u201310.","journal-title":"Public Health Genomics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13408-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:02:37Z","timestamp":1736229757000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13408-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13408"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13408-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study materials and procedures were approved by the Columbia University Irving Medical Center (CUIMC) Institutional Review Board\u00a0(IRB-AAAR3676). Individual informed consent was granted by interviewed study participants through an online informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}